Award details

Combinatorial bioformulation of epidermal growth factors

ReferenceBB/C50466X/1
Principal Investigator / Supervisor Dr Ana Maria Gonzalez
Co-Investigators /
Co-Supervisors
Professor Andrew Baird, Professor Martin Berry, Professor Margaret Lawrence, Professor Ann Logan
Institution University of Birmingham
DepartmentMedical Sciences - Medicine
Funding typeResearch
Value (£) 217,842
StatusCompleted
TypeResearch Grant
Start date 01/01/2005
End date 31/08/2008
Duration44 months

Abstract

Biopharmaceutical drug development is hampered by an inability to formulate proteins to enter the brain. Unlike small molecule drugs, biopharmaceuticals (e.g. antibodies, peptides and proteins) cannot be modified by rational design without having a profound - and often unexpected - effects on their biological activity. A multidisciplinary group of 5 co-applicants will apply a technique called Combinatorial Bioformulation to (1) identify peptide-chimera or epidermal growth factor (EGF) that translocate from blood into the CNS, (2) characterise their effects on CNS function and (3) establish a structural basis for their activity because EGF can stimulate stem cells, glia and neurons but only when it is introduced directly into the CNS.

Summary

unavailable
Committee Closed Committee - Engineering & Biological Systems (EBS)
Research TopicsNeuroscience and Behaviour, Pharmaceuticals
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file